OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of Combined Endothelin A Receptor and Renin-Angiotensin System Blockade on the Course of End-Organ Damage in 5/6 Nephrectomized Ren-2 Hypertensive Rats
Ivana Vaněčková, Petr Kujal, Zuzana Husková, et al.
Kidney & Blood Pressure Research (2012) Vol. 35, Iss. 5, pp. 382-392
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Metformin alleviates oxidative stress and enhances autophagy in diabetic kidney disease via AMPK/SIRT1-FoxO1 pathway
Huiwen Ren, Ying Shao, Can Wu, et al.
Molecular and Cellular Endocrinology (2019) Vol. 500, pp. 110628-110628
Closed Access | Times Cited: 253

Cardioprotective effect of virgin coconut oil in heated palm oil diet-induced hypertensive rats
Yusof Kamisah, Vengadesh Periyah, Kee Tat Lee, et al.
Pharmaceutical Biology (2015) Vol. 53, Iss. 9, pp. 1243-1249
Open Access | Times Cited: 39

Acute Liver Failure Induced by Thioacetamide: Selection of Optimal Dosage in Wistar and Lewis Rats
Eva Koblihová, Iveta Mrázová, Zdeňka Vernerová, et al.
Physiological Research (2014), pp. 491-503
Open Access | Times Cited: 39

Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren‐2 transgenic hypertensive rats
Petr Kujal, Věra Čertíková Chábová, Petra Škaroupková, et al.
Clinical and Experimental Pharmacology and Physiology (2014) Vol. 41, Iss. 3, pp. 227-237
Open Access | Times Cited: 38

Corosolic acid inhibits the proliferation of glomerular mesangial cells and protects against diabetic renal damage
Xiaoqiang Li, Wen Tian, Xiao-Xiao Liu, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 35

Addition of ETA receptor blockade increases renoprotection provided by renin–angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats
Věra Čertíková Chábová, Zdeňka Vernerová, Petr Kujal, et al.
Life Sciences (2013) Vol. 118, Iss. 2, pp. 297-305
Open Access | Times Cited: 26

Soluble Epoxide Hydrolase Inhibition Exhibits Antihypertensive Actions Independently of Nitric Oxide in Mice with Renovascular Hypertension
Libor Kopkan, Zuzana Husková, Alexandra Sporková, et al.
Kidney & Blood Pressure Research (2012) Vol. 35, Iss. 6, pp. 595-607
Open Access | Times Cited: 25

Rutin ameliorates renal fibrosis and proteinuria in 5/6-nephrectomized rats by anti-oxidation and inhibiting activation of TGFβ1-smad signaling.
Yu Han, Jinshan Lu, Yong Xu, et al.
PubMed (2015) Vol. 8, Iss. 5, pp. 4725-34
Closed Access | Times Cited: 24

Tacrolimus-induced hypertension and nephrotoxicity in Fawn-Hooded rats are attenuated by dual inhibition of renin–angiotensin system
Lenka Hošková, Ivan Málek, Josef Kautzner, et al.
Hypertension Research (2014) Vol. 37, Iss. 8, pp. 724-732
Open Access | Times Cited: 23

A branched arabinoglucan from Angelica sinensis ameliorates diabetic renal damage in rats
Yi Sui, Wenjuan Liu, Wen Tian, et al.
Phytotherapy Research (2019) Vol. 33, Iss. 3, pp. 818-831
Closed Access | Times Cited: 20

Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: Studies in Cyp1a1-Ren-2 transgenic rats
Alexandra Sporková, Šárka Jíchová, Zuzana Husková, et al.
Clinical and Experimental Pharmacology and Physiology (2014) Vol. 41, Iss. 12, pp. 1003-1013
Open Access | Times Cited: 21

Renin–angiotensin system blockade alone or combined with ETA receptor blockade: effects on the course of chronic kidney disease in 5/6 nephrectomized Ren-2 transgenic hypertensive rats
Lenka Sedláková, Věra Čertíková Chábová, Šárka Doleželová, et al.
Clinical and Experimental Hypertension (2017) Vol. 39, Iss. 2, pp. 183-195
Closed Access | Times Cited: 19

Antihypertensive and metabolic effects of empagliflozin in Ren-2 transgenic rats, an experimental non-diabetic model of hypertension
Silvie Hojná, Hana Rauchová, Hana Malínská, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112246-112246
Open Access | Times Cited: 16

Ombuin ameliorates diabetic nephropathy in rats by anti‐inflammation and antifibrosis involving Notch 1 and PPAR γ signaling pathways
Bin Liu, Caichun Deng, Ping Tan
Drug Development Research (2022) Vol. 83, Iss. 6, pp. 1270-1280
Closed Access | Times Cited: 11

Antihypertensive and renoprotective actions of soluble epoxide hydrolase inhibition in ANG II-dependent malignant hypertension are abolished by pretreatment with L-NAME
Zuzana Honetschlägerová, Kento Kitada, Zuzana Husková, et al.
Journal of Hypertension (2012) Vol. 31, Iss. 2, pp. 321-332
Open Access | Times Cited: 19

Renoprotective Effects of ETA Receptor Antagonists Therapy in Experimental Non-Diabetic Chronic Kidney Disease: Is There Still Hope for the Future?
Ivana Vaněčková, Silvie Hojná, Michaela Kadlecová, et al.
Physiological Research (2018), pp. S55-S67
Open Access | Times Cited: 17

Endothelin Receptor A Blockade Is an Ineffective Treatment for Adriamycin Nephropathy
Roderick J. Tan, Lili Zhou, Dong Zhou, et al.
PLoS ONE (2013) Vol. 8, Iss. 11, pp. e79963-e79963
Open Access | Times Cited: 15

Contribution of Selected Vasoactive Systems to Blood Pressure Regulation in Two Models of Chronic Kidney Disease
Natálie Drábková, Silvie Hojná, Josef Zicha, et al.
Physiological Research (2020), pp. 405-414
Open Access | Times Cited: 14

Cardiac and Renal Effects of Atrasentan in Combination with Enalapril and Paricalcitol in Uremic Rats
Cynthia S. Ritter, Sarah Zhang, Jane Finch, et al.
Kidney & Blood Pressure Research (2014) Vol. 39, Iss. 4, pp. 340-352
Open Access | Times Cited: 13

Endothelin type A receptor blockade increases renoprotection in congestive heart failure combined with chronic kidney disease: Studies in 5/6 nephrectomized rats with aorto-caval fistula
Petr Kala, Zdeňka Vaňourková, Petra Škaroupková, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114157-114157
Open Access | Times Cited: 8

Nicousamide attenuates renal dysfunction and glomerular injury in remnant kidneys by inhibiting TGF-β1 internalisation and renin activity
Sen Zhang, Weida Wang, Yan Li, et al.
European Journal of Pharmacology (2018) Vol. 845, pp. 74-84
Closed Access | Times Cited: 8

Moderate additive effects of endothelin receptor A blockade in Ren-2 transgenic rats subjected to various types of RAS blockade
Ivana Vaněčková, Lenka Řezáčová, Jaroslav Kuneš, et al.
Life Sciences (2016) Vol. 159, pp. 127-134
Closed Access | Times Cited: 6

Page 1 - Next Page

Scroll to top